In fibrotic MASLD samples, the Aβ-42-degrading enzymes ACE, MMP2, and MMP7 were enhanced, while the expression of APEH, ECE1, and MBP was reduced (Figure 5C). Here, MMP2 is linked to metabolic dysfunction-associated steatotic liver disease.